A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

A single dose of the RSVPreF3 OA vaccine offers strong protection against RSV-related lower respiratory tract disease in ...

Respiratory syncytial virus (RSV) is a negative-stranded ... are the primary targets of the humoral response. RSV is a major seasonal viral respiratory pathogen in infants, young children ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

For respiratory conditions like influenza and Respiratory Syncytial Virus (RSV), mRNA vaccines ... across a wide disease spectrum- from seasonal viruses to chronic, life-threatening, and ...

“These are respiratory illnesses that can ... “Influenza is a particularly challenging virus as it mutates in a seasonal pattern. The rate of change to the mutations can impact how quickly ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...

The CDC’s Advisory Committee on Immunization Practices voted April 16 to expand use of respiratory syncytial virus vaccines among high-risk adults. The updated recommendation calls for a single ...

As spring temperatures rise along with pollen counts in Georgia, the state is seeing a decline in winter respiratory ...